Morris Kandinov LLP represents shareholders of 26 Capital Acquisition Corp. in connection with its failed merger with a Philippines-based casino and related misconduct by the SPAC’s officers and directors. By […]
The Delaware Court of Chancery approved a class settlement of claims against Aytu BioPharma Inc. and directors relating to affiliated transactions and trading.
A running log of legal and regulatory developments in the world of closed end funds packaged with unsolicited and (sometimes) insightful pro-investor commentary.
Lead plaintiff ATG Fund II LLC has filed for final approval of a $7 million settlement of claims arising from the liquidation of VPC Impact Acquisition Holdings II, a special purpose acquisition company.
Aaron Morris submitted a written comment to the Securities & Exchange Commission in connection with an ill-conceived proposal to exempt closed-end funds from the annual shareholder meeting requirement.
Morris Kandinov LLP, on behalf of the lead plaintiff, filed motions for final approval and for reimbursement of fees and expenses in connection with SPAC settlement.